Closed Loop Medicine Wants To Deliver Upon Its Name, Tailoring Drug Dosages
The company is developing combination products that link software and therapeutics to personalize drug and care regimens.
You may also be interested in...
The company is trialing absorbable implants for both cosmetic and reconstructive surgeries.
In this edition of Medtech Monthly, Robert Gabbay, chief scientific and medical officer for the American Diabetes Association talked to Medtech Insight about diabetes tech, where it's headed, and what it could mean for preventative care.
An interactive view of medtech executive changes from the month of July 2022.